Loading…
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.1% | −7.5% | +5.6% | −10.8% | +18.0% | +28.4% | — | — | — | +72.8% |
| Peer average | −1.4% | −4.2% | −6.2% | −8.1% | +3.0% | +4.3% | +67.7% | +6.9% | +318.7% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$106 of every $1,000 in LFSC is Replimune
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | REPLReplimune Group | Healthcare | 10.59% | $1,059.04 | 616K | $12.7M |
| 2 | LIVNLivaNova | Healthcare | 8.15% | $814.92 | 105K | $9.8M |
| 3 | TVTXTravere Therapeutics | Healthcare | 5.74% | $574.34 | 139K | $6.9M |
| 4 | COGTCogent Biosciences | Healthcare | 5.30% | $530.01 | 234K | $6.3M |
| 5 | GHGuardant Health | Healthcare | 4.51% | $450.58 | 37K | $5.4M |
| 6 | BLLNBilliontoone | Healthcare | 4.34% | $433.76 | 54K | $5.2M |
| 7 | SYRESpyre Therapeutics | Healthcare | 4.12% | $412.20 | 51K | $4.9M |
| 8 | CORTCorcept Therapeutics | Healthcare | 4.05% | $404.73 | 69K | $4.8M |
| 9 | TMDXTransMedics Group | Healthcare | 3.91% | $390.74 | 50K | $4.7M |
| 10 | UTHRUnited Therapeutics | Healthcare | 3.88% | $387.70 | 7,982 | $4.6M |
| 11 | MANEVeraDermics | Healthcare | 3.85% | $384.59 | 37K | $4.6M |
| 12 | MIRMMirum Pharmaceuticals | Healthcare | 3.73% | $373.42 | 49K | $4.5M |
| 13 | ICUIICU Medical | Healthcare | 3.05% | $305.26 | 20K | $3.7M |
| 14 | CYTKCytokinetics | Healthcare | 2.72% | $271.80 | 62K | $3.3M |
| 15 | AXSMAxsome Therapeutics | Healthcare | 2.61% | $260.96 | 23K | $3.1M |
LFSC does not pay a distribution.
of the $46.3B in 27 Disruptive tech ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | REPL | Replimune Group | 10.59% |
| 2 | LIVN | LivaNova | 8.15% |
| 3 | TVTX | Travere Therapeutics | 5.74% |
| 4 | COGT | Cogent Biosciences | 5.30% |
| 5 | GH | Guardant Health | 4.51% |
| 6 | BLLN | Billiontoone | 4.34% |
| 7 | SYRE | Spyre Therapeutics | 4.12% |
| 8 | CORT | Corcept Therapeutics | 4.05% |
| 9 | TMDX | TransMedics Group | 3.91% |
| 10 | UTHR | United Therapeutics | 3.88% |
Estimated yearly cost excludes trading costs and assumes constant assets.
No payouts on record: […]